Advancements In Enzyme Replacement Therapy For Exocrine Pancreatic Insufficiency In Chronic Pancreatitis Is Affecting The Direction Of The Chronic Pancreatitis (CP) Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Value Trend Is Expected For The Chronic Pancreatitis (CP) Market From 2026 To 2030?

The chronic pancreatitis (cp) market size has demonstrated robust expansion in recent years. Projections indicate it will advance from $5.23 billion in 2025 to $5.56 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.4%. This historical development can be attributed to several factors, including enhanced availability of diagnostic imaging, increased understanding of pancreatic disorders, broader application of pain management therapies, the expansion of gastroenterology services, and improved supportive care alternatives.

The chronic pancreatitis (cp) market size is anticipated to demonstrate significant growth in the coming years, with projections indicating an expansion to $7.05 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.1%. This forecasted growth is largely attributable to the progressive development of advanced enzyme formulations, an increased emphasis on early-stage intervention, the broader implementation of outpatient treatment models, the rising integration of nutrition-based therapies, and elevated investment in pancreatic disease research. Prominent trends throughout the forecast period are expected to include the escalating use of enzyme replacement therapies, the increasing adoption of minimally invasive endoscopic treatments, a heightened focus on nutritional management, the extension of personalized treatment plans, and a stronger emphasis on early diagnosis.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21146&type=smp

What Influential Factors Are Boosting The Chronic Pancreatitis (CP) Market Demand?

Elevated alcohol intake is projected to fuel the expansion of the chronic pancreatitis market moving forward. Alcohol consumption entails ingesting beverages containing ethanol, often for recreational, social, or cultural reasons; however, excessive consumption can lead to dependency or health risks. This escalating consumption of alcohol is influenced by factors such as increased social acceptance, urbanization, evolving lifestyles, and stress management techniques, especially prevalent among younger demographics. Alcohol use contributes to chronic pancreatitis by initiating inflammation and damage within pancreatic cells, which in turn leads to fibrosis, blockages in ducts, and long-term dysfunction resulting from toxic metabolic byproducts. For example, in 2025, a 2023 survey by the Priory Group, a UK-based provider of mental health, addiction, and specialist education services, reported that 25% of UK individuals aged 18–24 now completely abstain from alcohol, showcasing a notable trend towards sobriety among the younger generation. Therefore, the rising consumption of alcohol is a key driver for the growth of the chronic pancreatitis market.

Which Segment-Based Categories Are Covered In The Chronic Pancreatitis (CP) Market?

The chronic pancreatitis (cp) market covered in this report is segmented –

1) By Treatment: Analgesic, Artificial Digestive Enzyme, Protein Supplements, Other Treatments

2) By Diagnosis: Computed Tomography (CT) Scan, Magnetic Resonance Cholangiopancreatography, Ultrasound Sonography, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospitals, Homecare, Other End Users

Subsegments:

1) By Analgesic: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids

2) By Artificial Digestive Enzyme: Pancrelipase, Pancreatin

3) By Protein Supplements: Branched-Chain Amino Acids (BCAA), Whey Protein

4) By Other Treatments: Endoscopic Treatment, Surgery

What Trends Are Influencing The Future Of The Chronic Pancreatitis (CP) Market?

Leading companies within the chronic pancreatitis market are concentrating on developing technological innovations, including enzyme replacement therapy, to manage exocrine pancreatic insufficiency (EPI) linked to chronic pancreatitis. This therapy entails the ingestion of oral pancreatic enzymes to support digestion for individuals with inadequate pancreatic function. For example, in July 2023, First Wave BioPharma Inc, a US-based clinical-stage biopharmaceutical firm, disclosed the outcomes from its Phase 2 SPAN clinical trial. This trial explored an improved enteric microgranule delivery formulation of adrulipase for addressing exocrine pancreatic insufficiency (EPI) in patients with both cystic fibrosis (CF) and chronic pancreatitis. Adrulipase, a recombinant lipase enzyme originating from the Yarrowia lipolytica yeast, is administered as an oral, non-systemic biologic capsule. Its design facilitates the breakdown of fat molecules within the digestive tract of EPI patients, thereby enabling their absorption as nutrients.

Who Are The Firms Contributing To The Chronic Pancreatitis (CP) Market Ecosystem?

Major companies operating in the chronic pancreatitis (cp) market are Pfizer, Johnson & Johnson, Merck & Co Inc, AbbVie Inc, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Baxter, CSL Behring, Octapharma AG, Dr. Reddy’s Laboratories, Nestle Health Science, Cerata Pharmaceuticals, Unichem Laboratories Ltd, LGM Pharma, Aptalis Pharmaceutical Technologies, Digestive Care Inc, Akron Biotech

Access The Complete Chronic Pancreatitis (CP) Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-pancreatitis-cp-global-market-report

Which Region Is The Dominant Market In The Chronic Pancreatitis (CP) Market?

North America was the largest region in the chronic pancreatitis (CP) market in 2025. The regions covered in the chronic pancreatitis (cp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Chronic Pancreatitis (CP) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21146&type=smp

Browse Through More Reports Similar to the Global Chronic Pancreatitis (CP) Market 2026, By The Business Research Company

Chronic Pain Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Virtual Reality In Healthcare Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-reality-in-healthcare-global-market-report

Virtual Reality Vr In Medical Simulation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-reality-vr-in-medical-simulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795